By SHEILA FRAME FDA Commissioner Scott Gottlieb has said biosimilars are “key to promoting access and reducing health care costs. And it’s a key to advancing public health.” While the Administration works to reduce barriers to bringing biosimilars to
Read More...
Read the complete post at http://thehealthcareblog.com/blog/2018/12/20/increased-payer-and-provider-support-may-drive-billions-of-dollars-in-savings-from-biosimilars/
Posted
Dec 20 2018, 06:30 AM
by
THCB